Pharmacist-Led Medication Review: Supports for New Role of Pharmacists

  • Kourosh Sadeghi Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Mehdi Mohammadi Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Farhad Najmeddin Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Mojgan Mashayekhi Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Mojtaba Mojtahedzadeh Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran AND Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran
  • MohammadReza Javadi Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Kheirollah Gholami Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran AND Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran
Keywords: Pharmacist, Drug Therapy, Patient Care, Pharmaceutical Services

Abstract

In recent decades, by increasing complexity of drug therapy, pharmacists considered as health- care members who can help optimizing drug therapy. We know that medicines do not have the anticipated effects all the times and a vast variability may exist in their behaviors in the body. So, it is very crucial to individualize treatment for every single patient. Nowadays, optimizing drug therapy in patients needs a collaborative interdisciplinary approach to patients care and treatment. Specifically when drug therapy is considered for a condition, pharmacists can enroll as a valuable professional to help for modification of therapy along with other clinicians. Abundant number of studies and reports exist in the literatures which address usefulness of pharmacist engagement in patient care. In this review we have presented some valuable evidences supporting pharmacist role in different clinical settings.

References

Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47(3):533-43.

Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP 1990;24(11):1093-7.

Williams M, Peterson GM, Tenni PC, Bindoff IK, Stafford AC. DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm 2012; 34(1):43-52.

Blix HS, Viktil KK, Reikvam A, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004; 60(9):651-8.

Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H, Group E-SRCPR. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci 2004;26(6):353-60.

Ellitt GR, Engblom E, Aslani P, Westerlund T, Chen TF. Drug related problems after discharge from an Australian teaching hospital. Pharm World Sci 2010; 32(5):622-30.

Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Brit J Clin Pharmacol 2012;74(4):573-80.

Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care 2010; 48(10):923-33.

Vinks TH, Egberts TC, de Lange TM, de Koning FH. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging 2009; 26(2):123-33.

Christensen M, Lundh A. Medication review in hospitalized patients to reduce morbidity and mortality. Cochrane Database Syst Rev 2013; 2:CD008986.

Teinilä T, Kaunisvesi K, Airaksinen M. Primary care physicians’ perceptions of medication errors and error prevention in cooperation with community pharmacists. Res Social Adm Pharm 2011; 7(2):162-79.

Patanwala AE, Warholak TL, Sanders AB, Erstad BL. A prospective observational study of medication errors in a tertiary care emergency department. Ann Emerg Med 2010; 55(6):522-6.

Patanwala AE, Sanders AB, Thomas MC, et al. A prospective, multicenter study of pharmacist activities resulting in medication error interception in the emergency department. Ann Emerg Med 2012; 59(5):369-73.

Jellinek SP, Cohen V, Fancher LB, et al. Pharmacist improves timely administration of medications to boarded patients in the emergency department. J Emerg Nurs 2010; 36(2):105-10.

Rothschild JM, Churchill W, Erickson A, et al. Medication errors recovered by emergency department pharmacists. Ann Emerg Med 2010; 55(6):513- 21.

Cesarz JL, Steffenhagen AL, Svenson J, Hamedani AG. Emergency department discharge prescription interventions by emergency medicine pharmacists. Ann Emerg Med 2013; 61(2):209-14 e1.

Odum L, Whaley-Connell A. The Role of Team-Based Care Involving Pharmacists to Improve Cardiovascular and Renal Outcomes. Cardiorenal Med 2012; 2(4):243-50.

Kalisch LM, Roughead EE, Gilbert AL. Improving heart failure outcomes with pharmacist-physician collaboration: how close are we? Future Cardiol 2010; 6(2):255-68.

Peterson ED, Albert NM, Amin A, Patterson JH, Fonarow GC. Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management. Am J Cardiol 2008; 102(5A):47G-56G.

Erhun WO, Agbani EO, Bolaji EE. Positive benefits of a pharmacistmanaged hypertension clinic in Nigeria. Public Health 2005; 119(9):792-8.

Charrois TL, McAlister FA, Cooney D, et al. Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods. Implement Sci 2011; 6:94.

Fikri-Benbrahim N, Faus MJ, Martinez-Martinez F, Sabater-Hernandez D. Impact of a community pharmacists’ hypertension-care service on medication adherence. The AFenPA study. Res Social Adm Pharm 2013. pii: S1551-7411(13)00005-3.

Houle SK, Chuck AW, McAlister FA, Tsuyuki RT. Effect of a pharmacistmanaged hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Pharmacotherapy 2012; 32(6):527-37.

Lowrie R, Mair FS, Greenlaw N, et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J 2012; 33(3):314-24.

Barker A, Barlis P, Berlowitz D, Page K, Jackson B, Lim WK. Pharmacist directed home medication reviews in patients with chronic heart failure: a randomised clinical trial. Int J Cardiol 2012; 159(2):139-43.

Acquisto NM, Hays DP, Fairbanks RJ, et al. The outcomes of emergency pharmacist participation during acute myocardial infarction. J Emerg Med 2012; 42(4):371-8.

Snider M, Kalbfleisch S, Carnes CA. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review. Clin Ther 2009; 31(6):1209-18.

Donovan JL, Drake JA, Whittaker P, Tran MT. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance. J Thromb Thrombolysis 2006; 22(1):23-30.

Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm 2012; 18(7):516-26.

Warrington L, Ayers P, Baldwin AM, et al. Implementation of a pharmacistled, multidisciplinary diabetes management team. Am J Health Syst Pharm 2012; 69(14):1240-5.

Venkatesan R, Devi AS, Parasuraman S, Sriram S. Role of community pharmacists in improving knowledge and glycemic control of type 2 diabetes. Perspect Clin Res 2012; 3(1):26-31.

Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011; 16(1):43-9.

Salvo MC, Brooks AM. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs. standard care. Ann Pharmacother 2012; 46(1):29-34.

Vivian EM. The pharmacist’s role in maintaining adherence to insulin therapy in type 2 diabetes mellitus. Consult Pharm 2007; 22(4):320-32.

Taveira TH, Dooley AG, Cohen LB, Khatana SA, Wu WC. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults. Ann Pharmacother 2011; 45(11):1346-55.

Grossman S. Management of type 2 diabetes mellitus in the elderly: role of the pharmacist in a multidisciplinary health care team. J Multidiscip Healthc 2011; 4:149-54.

Collins C, Limone BL, Scholle JM, Coleman CI. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract 2011; 92(2):145-52.

Mularski KS, Yeh CP, Bains JK, Mosen DM, Hill AK, Mularski RA. Pharmacist glycemic control team improves quality of glycemic control in surgical patients with perioperative dysglycemia. Perm J 2012; 16(1):28-33.

Mason NA. Polypharmacy and medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens 2011; 20(5):492-7.

Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease. Pharmacotherapy 2007; 27(5):734-44.

St Peter WL, Farley TM, Carter BL. Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients. Curr Opin Nephrol Hypertens 2011; 20(5):498-503.

Sathvik B S, Mangasuli S, Narahari M G, Gurudev K C, Parthasarathi G. Medication knowledge of hemodialysis patients and influence of clinical pharmacist provided education on their knowledge. Indian J Pharm Sci 2007; 69(2):232-9

Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy 2009; 29(12):1433-40.

Pai AB, Boyd A, Chavez A, Manley HJ. Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2-year randomized, controlled study. Hemodial Int 2009; 13(1):72-9.

Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol 2011; 12:35.

Manley HJ, Carroll CA. The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial 2002; 15(1):45-9.

Mirkov S. Implementation of a pharmacist medication review clinic for haemodialysis patients. N Z Med J 2009; 122(1297):25-37.

Ibrahim KH, Gunderson B, Rotschafer JC. Intensive care unit antimicrobial resistance and the role of the pharmacist. Crit Care Med 2001; 29(4 Suppl):N108-13.

Gums JG, Yancey RW, Jr., Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 1999; 19(12):1369-77.

Hand K. Antibiotic pharmacists in the ascendancy. J Antimicrob Chemother 2007; 60 Suppl 1:i73-6.

Camire E, Moyen E, Stelfox HT. Medication errors in critical care: risk factors, prevention and disclosure. CMAJ 2009; 180(9):936-43.

Moyen E, Camire E, Stelfox HT. Clinical review: medication errors in critical care. Crit Care 2008; 12(2):208.

Kiekkas P, Karga M, Lemonidou C, Aretha D, Karanikolas M. Medication errors in critically ill adults: a review of direct observation evidence. Am J Crit Care 2011; 20(1):36-44.

Rivkin A, Yin H. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients. J Crit Care 2011; 26(1): 104 e1-6.

MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med 2008; 36(12):3184-9.

MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy 2009; 29(7):761-8.

Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists onenhancing patient outcomes. Intensive Care Med 2003; 29(5):691-8.

Carcelero E, Anglada H, Tuset M, Creus N. Interactions between oral antineoplastic agents and concomitant medication: a systematic review. Expert Opin Drug Saf 2013; 12(3):403-20.

Watts RG, Parsons K. Chemotherapy Medication Errors in a Pediatric Cancer Treatment Center: Prospective Characterization of Error Types and Frequency and Development of a Quality Improvement Initiative to Lower the Error Rate. Pediatr Blood Cancer 2013;60(8):1320-4.

van Leeuwen RW, Brundel DH, Neef C, et al. Prevalence of potential drugdrug interactions in cancer patients treated with oral anticancer drugs. Br J Cancer 2013; 108(5):1071-8.

Yeoh TT, Si P, Chew L. The impact of medication therapy management in older oncology patients. Support Care Cancer 2013; 21(5):1287-93.

Ho L, Akada K, Messner H, Kuruvilla J, Wright J, Seki JT. Pharmacist’s Role in Improving Medication Safety for Patients in an Allogeneic Hematopoietic Cell Transplant Ambulatory Clinic. Can J Hosp Pharm 2013; 66(2):110-7.

Fialova D, Onder G. Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol 2009; 67(6):641-5.

Szczepura A, Wild D, Nelson S. Medication administration errors for older people in long-term residential care. BMC Geriatr 2011; 11:82.

Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Gregoire JP. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr 2004; 4:9.

Milos V, Rekman E, Bondesson A, et al. Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study. Drugs Aging 2013; 30(4):235-46.

Hanlon JT, Lindblad CI, Gray SL. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am J Geriatr Pharmacother 2004; 2(1):3-13.

Chhabra PT, Rattinger GB, Dutcher SK, Hare ME, Parsons KL, Zuckerman IH. Medication reconciliation during the transition to and from long-term care settings: a systematic review. Res Social Adm Pharm 2012; 8(1):60-75.

Kassam R, Meneilly GS. Role of the Pharmacist on a Multidisciplinary Diabetes Team. Canadian Journal of Diabetes 2007; 31(3):215-22.

Hussainy SY, Box M, Scholes S. Piloting the role of a pharmacist in a community palliative care multidisciplinary team: an Australian experience. BMC Palliat Care 2011; 10:16.

Pottie K, Haydt S, Farrell B, et al. Pharmacist’s identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT project. Res Social Adm Pharm 2009; 5(4):319-26. 72. Kwint HF, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The

relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging 2013; 30(2):91-102.

Farrell B, Ward N, Dore N, Russell G, Geneau R, Evans S. Working in interprofessional primary health care teams: What do pharmacists do? Res Social Adm Pharm 2012; 9(3):288-301

Leendertse AJ, de Koning GH, Goudswaard AN, et al. Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. J Clin Pharm Ther 2013; 38(5):379-87.

Bellone JM, Barner JC, Lopez DA. Postdischarge interventions by pharmacists and impact on hospital readmission rates. J Am Pharm Assoc (2003). 2012; 52(3):358-62.

Kilcup M, Schultz D, Carlson J, Wilson B. Postdischarge pharmacist medication reconciliation: Impact on readmission rates and financial savings. J Am Pharm Assoc (2003). 2013; 53(1):78-84.

Dashti-Khavidaki S, Sharif Z, Khalili H, et al. The use of pharmaceutical care to improve health-related quality of life in hemodialysis patients in Iran. Int J Clin Pharm 2013; 35(2):260-7.

Thatcher EE, Vanwert EM, Erickson SR. Potential Impact of Pharmacist Interventions to Reduce Cost for Medicare Part D Beneficiaries. J Pharm Pract 2012; 26(3):248-52.

Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006; 166(9):955-64.

Van C, Costa D, Abbott P, Mitchell B, Krass I. Community pharmacist attitudes towards collaboration with general practitioners: development and validation of a measure and a model. BMC Health Serv Res 2012; 12:320.

da Silva NMM. The impact of pharmacist participation in a multidisciplinary team on an oncology ward compared with a ward clinical pharmacy service. Eur J Hosp Pharm Sci Pract 2012; 19(2):259-60.

Published
2015-10-11
How to Cite
1.
Sadeghi K, Mohammadi M, Najmeddin F, Mashayekhi M, Mojtahedzadeh M, Javadi M, Gholami K. Pharmacist-Led Medication Review: Supports for New Role of Pharmacists. J Pharm Care. 1(4):153-160.
Section
Review Article(s)